Prostate cancer is the most common malignancy tumor among men in developed countries. The incidence rate in recent years is also increasing in China. With the development of technology, the application of PET/CT examination has been augmented in the diagnosis of prostate cancer. In order to detect prostate cancer more safely and effectively, new types of targeted tracer for PET/CT has been developed, including 18F-fluiclovine. 18F-fluiclovine has the characteristics of fast uptake, rapid development and fast metabolism, which has a good diagnostic rate for the recurrence and metastasis of prostate cancer. However, at present, there are few researches and its security, diagnosis efficiency, and application value still need further research to verify.
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2020 Feb 28 [Epub]
Kaiyun Wang, Rui Su, Xiaoyu Sun, Junhui Jiang, Qi Ma
School of Medicine, Ningbo University, Ningbo Zhejiang 315211 ., Department of Urology, Ningbo First Hospital, Ningbo Zhejiang 315010., School of Medicine, Ningbo University, Ningbo Zhejiang 315211., Translational Research Laboratory for Urology, Key Laboratory of Ningbo, Ningbo Zhejiang 315010, China .